NantKwest, Inc. Business Finance Contracts & Agreements

77 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between ImmunityBio, Inc. and Purchasers dated April 7, 2025
Purchase Agreements
NantKwest, Inc.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between ImmunityBio, Inc. and Holder (April 2025)
Warrant Agreements
NantKwest, Inc.
Biotechnology
2025
Limited Consent and Amendment to Revenue Interest Purchase Agreement among ImmunityBio, Inc., Purchasers, and Infinity SA LLC (December 10, 2024)
Purchase Agreements
NantKwest, Inc.
Biotechnology
2024
Second Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (December 2024)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2024
ImmunityBio, Inc. Underwriting Agreement with Jefferies LLC and Piper Sandler & Co. (December 2024)
Underwriting Agreements
NantKwest, Inc.
Biotechnology
NY
2024
ImmunityBio, Inc. 2015 Equity Incentive Plan (as Amended June 11, 2024)
Equity Distribution Agreements
NantKwest, Inc.
Biotechnology
DE
2024
Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (December 29, 2023)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2024
Letter Amendment to Convertible Promissory Notes between ImmunityBio, Inc. and Nant Capital, LLC (December 29, 2023)
Modification Agreements
NantKwest, Inc.
Biotechnology
2024
Stock Purchase and Option Agreement between ImmunityBio, Inc. and TPC Investments Entities (December 29, 2023)
Stock Agreements
NantKwest, Inc.
Biotechnology
NY
2024
Security and Pledge Agreement between ImmunityBio, Inc., Subsidiary Guarantors, and Infinity SA LLC (December 29, 2023)
Pledge Agreements
NantKwest, Inc.
Biotechnology
NY
2024
Revenue Interest Purchase Agreement among ImmunityBio, Inc., Purchasers, and Infinity SA LLC (December 29, 2023)
Purchase Agreements
NantKwest, Inc.
Biotechnology
DE
2024
Description of ImmunityBio, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
NantKwest, Inc.
Biotechnology
2024
ImmunityBio, Inc. $200 Million Convertible Promissory Note with Nant Capital, LLC (September 2023)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2023
Stock Purchase Agreement between ImmunityBio, Inc., NantCell, Inc., and Nant Entities (September 11, 2023)
Purchase Agreements
NantKwest, Inc.
Biotechnology
DE
2023
Amended Common Stock Purchase Warrant between ImmunityBio, Inc. and Holder (February 17, 2023)
Warrant Agreements
NantKwest, Inc.
Biotechnology
2023
Amendment to Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (September 2023)
Modification Agreements
NantKwest, Inc.
Biotechnology
2023
Amendment to Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (Maturity Date Extension)
Modification Agreements
NantKwest, Inc.
Biotechnology
2023
Amendment to Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (September 2023)
Modification Agreements
NantKwest, Inc.
Biotechnology
2023
Amendment to Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (Maturity Date Extension)
Modification Agreements
NantKwest, Inc.
Biotechnology
2023
Amendment to Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC (September 2023)
Modification Agreements
NantKwest, Inc.
Biotechnology
2023
Securities Purchase Agreement between ImmunityBio, Inc. and Purchasers dated July 20, 2023
Purchase Agreements
NantKwest, Inc.
Biotechnology
NY
2023
Common Stock Purchase Warrant Agreement between ImmunityBio, Inc. and Holder (July 2023)
Warrant Agreements
NantKwest, Inc.
Biotechnology
2023
Placement Agency Agreement between ImmunityBio, Inc. and Jefferies LLC (July 2023)
Equity Distribution Agreements
NantKwest, Inc.
Biotechnology
NY
2023
ImmunityBio, Inc. $30,000,000 Promissory Note Agreement with Nant Capital, LLC (June 13, 2023)
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2023
Common Stock Purchase Warrant Agreement between ImmunityBio, Inc. and Holder (February 2023)
Warrant Agreements
NantKwest, Inc.
Biotechnology
2023
Common Stock Purchase Warrant Agreement between ImmunityBio, Inc. and Holder (December 12, 2022)
Warrant Agreements
NantKwest, Inc.
Biotechnology
2022
ImmunityBio, Inc. $30 Million Convertible Promissory Note Agreement with Nant Capital, LLC (March 31, 2023)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2023
Securities Purchase Agreement between ImmunityBio, Inc. and Purchasers dated February 15, 2023
Purchase Agreements
NantKwest, Inc.
Biotechnology
NY
2023
Placement Agency Agreement between ImmunityBio, Inc. and Jefferies LLC (February 2023)
Equity Distribution Agreements
NantKwest, Inc.
Biotechnology
NY
2023
ImmunityBio, Inc. $50,000,000 Promissory Note Agreement with Nant Capital, LLC (December 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement between ImmunityBio, Inc. and Purchasers dated December 12, 2022
Purchase Agreements
NantKwest, Inc.
Biotechnology
NY
2022
Placement Agency Agreement between ImmunityBio, Inc. and Piper Sandler & Co. dated December 12, 2022
Underwriting Agreements
NantKwest, Inc.
Biotechnology
NY
2022
Second Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and NantMobile, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and NantCancerStemCell, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and NantWorks, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and Nant Capital, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and Nant Capital, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Convertible Promissory Note between NantCell, Inc., ImmunityBio, Inc., and Nant Capital, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
ImmunityBio, Inc. $125 Million Promissory Note Agreement with Nant Capital, LLC (August 31, 2022)
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2022